APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Antibacterial and Antibiotics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal Antibacterial and Antibiotics Market Outlook and Growth Opportunities 2026

20 December 2025208 pages

Choose your research edition.

Industry ResearchAnimal Antibacterial and Antibiotics Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Antibacterial and Antibiotics Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Animal Antibacterial and Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Antibacterial and Antibiotics Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Antibacterial and Antibiotics Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Animal Antibacterial and Antibiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal Antibacterial and Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Antibacterial and Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Antibacterial and Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal Antibacterial and Antibiotics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal Antibacterial and Antibiotics market include Biogénesis Bagó, Boehringer Ingelheim Vetmedica, Ceva Santé Animale, Dechra Pharmaceuticals, ECO Animal Health, Elanco, Huvepharma, Merial and Neogen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Animal Antibacterial and Antibiotics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Antibacterial and Antibiotics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Antibacterial and Antibiotics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Animal Antibacterial and Antibiotics market.

Animal Antibacterial and Antibiotics Segment by Company

Biogénesis Bagó

Boehringer Ingelheim Vetmedica

Ceva Santé Animale

Dechra Pharmaceuticals

ECO Animal Health

Elanco

Huvepharma

Merial

Neogen

Norbrook

Orion

Phibro Animal Health

Vétoquinol

Virbac

Vitafor

Bayer HealthCare

Merck Animal Health

Zoetis

Animal Antibacterial and Antibiotics Segment by Type

Cephalosporins

Tetracyclines

Penicillins

Sulfonamides

Macrolides

Aminoglycosides

Animal Antibacterial and Antibiotics Segment by Application

Livestock

Pets

Others

Animal Antibacterial and Antibiotics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Animal Antibacterial and Antibiotics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Animal Antibacterial and Antibiotics key companies, revenue, market share, and recent developments.

3. To split the Animal Antibacterial and Antibiotics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Animal Antibacterial and Antibiotics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal Antibacterial and Antibiotics significant trends, drivers, influence factors in global and regions.

6. To analyze Animal Antibacterial and Antibiotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Antibacterial and Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Antibacterial and Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Antibacterial and Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Antibacterial and Antibiotics industry.

Chapter 3: Detailed analysis of Animal Antibacterial and Antibiotics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Animal Antibacterial and Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Animal Antibacterial and Antibiotics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal Antibacterial and Antibiotics Industry Trends Table 2. Animal Antibacterial and Antibiotics Industry Drivers Table 3. Animal Antibacterial and Antibiotics Industry Opportunities and Challenges Table 4. Animal Antibacterial and Antibiotics Industry Restraints Table 5. Global Animal Antibacterial and Antibiotics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal Antibacterial and Antibiotics Revenue Share by Company (2021-2026) Table 7. Global Animal Antibacterial and Antibiotics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Animal Antibacterial and Antibiotics Key Company Manufacturing Base & Headquarters Table 9. Global Animal Antibacterial and Antibiotics Company, Product Type & Application Table 10. Global Animal Antibacterial and Antibiotics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Animal Antibacterial and Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cephalosporins Table 15. Significant Companies of Tetracyclines Table 16. Significant Companies of Penicillins Table 17. Significant Companies of Sulfonamides Table 18. Significant Companies of Macrolides Table 19. Significant Companies of Aminoglycosides Table 20. Global Animal Antibacterial and Antibiotics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Animal Antibacterial and Antibiotics Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Animal Antibacterial and Antibiotics Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Animal Antibacterial and Antibiotics Sales Value Share by Type (2021-2026) Table 24. Global Animal Antibacterial and Antibiotics Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Livestock Table 26. Significant Companies of Pets Table 27. Significant Companies of Others Table 28. Global Animal Antibacterial and Antibiotics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Animal Antibacterial and Antibiotics Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Animal Antibacterial and Antibiotics Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Animal Antibacterial and Antibiotics Sales Value Share by Application (2021-2026) Table 32. Global Animal Antibacterial and Antibiotics Sales Value Share by Application (2027-2032) Table 33. Global Animal Antibacterial and Antibiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Animal Antibacterial and Antibiotics Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Animal Antibacterial and Antibiotics Sales Value Share by Region (2021-2026) Table 36. Global Animal Antibacterial and Antibiotics Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Animal Antibacterial and Antibiotics Sales Value Share by Region (2027-2032) Table 38. Global Animal Antibacterial and Antibiotics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Animal Antibacterial and Antibiotics Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Animal Antibacterial and Antibiotics Sales Value Market Share by Country (2021-2026) Table 41. Global Animal Antibacterial and Antibiotics Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Animal Antibacterial and Antibiotics Sales Value Market Share by Country (2027-2032) Table 43. Biogénesis Bagó Company Information Table 44. Biogénesis Bagó Business Overview Table 45. Biogénesis Bagó Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Biogénesis Bagó Animal Antibacterial and Antibiotics Product Portfolio Table 47. Biogénesis Bagó Recent Development Table 48. Boehringer Ingelheim Vetmedica Company Information Table 49. Boehringer Ingelheim Vetmedica Business Overview Table 50. Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Product Portfolio Table 52. Boehringer Ingelheim Vetmedica Recent Development Table 53. Ceva Santé Animale Company Information Table 54. Ceva Santé Animale Business Overview Table 55. Ceva Santé Animale Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Ceva Santé Animale Animal Antibacterial and Antibiotics Product Portfolio Table 57. Ceva Santé Animale Recent Development Table 58. Dechra Pharmaceuticals Company Information Table 59. Dechra Pharmaceuticals Business Overview Table 60. Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Product Portfolio Table 62. Dechra Pharmaceuticals Recent Development Table 63. ECO Animal Health Company Information Table 64. ECO Animal Health Business Overview Table 65. ECO Animal Health Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ECO Animal Health Animal Antibacterial and Antibiotics Product Portfolio Table 67. ECO Animal Health Recent Development Table 68. Elanco Company Information Table 69. Elanco Business Overview Table 70. Elanco Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Elanco Animal Antibacterial and Antibiotics Product Portfolio Table 72. Elanco Recent Development Table 73. Huvepharma Company Information Table 74. Huvepharma Business Overview Table 75. Huvepharma Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Huvepharma Animal Antibacterial and Antibiotics Product Portfolio Table 77. Huvepharma Recent Development Table 78. Merial Company Information Table 79. Merial Business Overview Table 80. Merial Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merial Animal Antibacterial and Antibiotics Product Portfolio Table 82. Merial Recent Development Table 83. Neogen Company Information Table 84. Neogen Business Overview Table 85. Neogen Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Neogen Animal Antibacterial and Antibiotics Product Portfolio Table 87. Neogen Recent Development Table 88. Norbrook Company Information Table 89. Norbrook Business Overview Table 90. Norbrook Animal Antibacterial and Antibiotics Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Norbrook Animal Antibacterial and Antibiotics Product Portfolio Table 92. Norbrook Recent Development Table 93. Orion Company Information Table 94. Orion Business Overview Table 95. Orion Animal Antibacterial and Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Orion Animal Antibacterial and Antibiotics Product Portfolio Table 97. Orion Recent Development Table 98. Phibro Animal Health Company Information Table 99. Phibro Animal Health Business Overview Table 100. Phibro Animal Health Animal Antibacterial and Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Phibro Animal Health Animal Antibacterial and Antibiotics Product Portfolio Table 102. Phibro Animal Health Recent Development Table 103. Vétoquinol Company Information Table 104. Vétoquinol Business Overview Table 105. Vétoquinol Animal Antibacterial and Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Vétoquinol Animal Antibacterial and Antibiotics Product Portfolio Table 107. Vétoquinol Recent Development Table 108. Virbac Company Information Table 109. Virbac Business Overview Table 110. Virbac Animal Antibacterial and Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Virbac Animal Antibacterial and Antibiotics Product Portfolio Table 112. Virbac Recent Development Table 113. Vitafor Company Information Table 114. Vitafor Business Overview Table 115. Vitafor Animal Antibacterial and Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Vitafor Animal Antibacterial and Antibiotics Product Portfolio Table 117. Vitafor Recent Development Table 118. Bayer HealthCare Company Information Table 119. Bayer HealthCare Business Overview Table 120. Bayer HealthCare Animal Antibacterial and Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Bayer HealthCare Animal Antibacterial and Antibiotics Product Portfolio Table 122. Bayer HealthCare Recent Development Table 123. Merck Animal Health Company Information Table 124. Merck Animal Health Business Overview Table 125. Merck Animal Health Animal Antibacterial and Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Merck Animal Health Animal Antibacterial and Antibiotics Product Portfolio Table 127. Merck Animal Health Recent Development Table 128. Zoetis Company Information Table 129. Zoetis Business Overview Table 130. Zoetis Animal Antibacterial and Antibiotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Zoetis Animal Antibacterial and Antibiotics Product Portfolio Table 132. Zoetis Recent Development Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Animal Antibacterial and Antibiotics Product Image Figure 2. Global Animal Antibacterial and Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Antibacterial and Antibiotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal Antibacterial and Antibiotics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cephalosporins Image Figure 8. Tetracyclines Image Figure 9. Penicillins Image Figure 10. Sulfonamides Image Figure 11. Macrolides Image Figure 12. Aminoglycosides Image Figure 13. Global Animal Antibacterial and Antibiotics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Animal Antibacterial and Antibiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Animal Antibacterial and Antibiotics Sales Value Share by Type (2021-2032) Figure 16. Livestock Image Figure 17. Pets Image Figure 18. Others Image Figure 19. Global Animal Antibacterial and Antibiotics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Animal Antibacterial and Antibiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Animal Antibacterial and Antibiotics Sales Value Share by Application (2021-2032) Figure 22. Global Animal Antibacterial and Antibiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Animal Antibacterial and Antibiotics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Animal Antibacterial and Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 25. North America Animal Antibacterial and Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Animal Antibacterial and Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Animal Antibacterial and Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Animal Antibacterial and Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Animal Antibacterial and Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Animal Antibacterial and Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 31. South America Animal Antibacterial and Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Animal Antibacterial and Antibiotics Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Animal Antibacterial and Antibiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Cephalosporins
  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
Applications
  • Livestock
  • Pets
  • Others
Companies covered
  • Biogénesis Bagó
  • Boehringer Ingelheim Vetmedica
  • Ceva Santé Animale
  • Dechra Pharmaceuticals
  • ECO Animal Health
  • Elanco
  • Huvepharma
  • Merial
  • Neogen
  • Norbrook
  • Orion
  • Phibro Animal Health
  • Vétoquinol
  • Virbac
  • Vitafor
  • Bayer HealthCare
  • Merck Animal Health
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Animal Antibacterial and Antibiotics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Animal Antibacterial and Antibiotics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Animal Antibacterial and Antibiotics Market Dynamics
  1. 2.1 Animal Antibacterial and Antibiotics Industry Trends
  2. 2.2 Animal Antibacterial and Antibiotics Industry Drivers
  3. 2.3 Animal Antibacterial and Antibiotics Industry Opportunities and Challenges
  4. 2.4 Animal Antibacterial and Antibiotics Industry Restraints
3 Animal Antibacterial and Antibiotics Market by Company
  1. 3.1 Global Animal Antibacterial and Antibiotics Company Revenue Ranking in 2025
  2. 3.2 Global Animal Antibacterial and Antibiotics Revenue by Company (2021-2026)
  3. 3.3 Global Animal Antibacterial and Antibiotics Company Ranking (2024-2026)
  4. 3.4 Global Animal Antibacterial and Antibiotics Company Manufacturing Base and Headquarters
  5. 3.5 Global Animal Antibacterial and Antibiotics Company Product Type and Application
  6. 3.6 Global Animal Antibacterial and Antibiotics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Animal Antibacterial and Antibiotics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Animal Antibacterial and Antibiotics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Animal Antibacterial and Antibiotics Market by Type
  1. 4.1 Animal Antibacterial and Antibiotics Type Introduction
  2. 4.1.1 Cephalosporins
  3. 4.1.2 Tetracyclines
  4. 4.1.3 Penicillins
  5. 4.1.4 Sulfonamides
  6. 4.1.5 Macrolides
  7. 4.1.6 Aminoglycosides
  8. 4.2 Global Animal Antibacterial and Antibiotics Sales Value by Type
  9. 4.2.1 Global Animal Antibacterial and Antibiotics Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Animal Antibacterial and Antibiotics Sales Value by Type (2021-2032)
  11. 4.2.3 Global Animal Antibacterial and Antibiotics Sales Value Share by Type (2021-2032)
5 Animal Antibacterial and Antibiotics Market by Application
  1. 5.1 Animal Antibacterial and Antibiotics Application Introduction
  2. 5.1.1 Livestock
  3. 5.1.2 Pets
  4. 5.1.3 Others
  5. 5.2 Global Animal Antibacterial and Antibiotics Sales Value by Application
  6. 5.2.1 Global Animal Antibacterial and Antibiotics Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Animal Antibacterial and Antibiotics Sales Value by Application (2021-2032)
  8. 5.2.3 Global Animal Antibacterial and Antibiotics Sales Value Share by Application (2021-2032)
6 Animal Antibacterial and Antibiotics Regional Value Analysis
  1. 6.1 Global Animal Antibacterial and Antibiotics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Antibacterial and Antibiotics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Animal Antibacterial and Antibiotics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Animal Antibacterial and Antibiotics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Animal Antibacterial and Antibiotics Sales Value (2021-2032)
  7. 6.3.2 North America Animal Antibacterial and Antibiotics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Animal Antibacterial and Antibiotics Sales Value (2021-2032)
  10. 6.4.2 Europe Animal Antibacterial and Antibiotics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Animal Antibacterial and Antibiotics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Animal Antibacterial and Antibiotics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Animal Antibacterial and Antibiotics Sales Value (2021-2032)
  16. 6.6.2 South America Animal Antibacterial and Antibiotics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Animal Antibacterial and Antibiotics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Animal Antibacterial and Antibiotics Sales Value Share by Country, 2025 VS 2032
7 Animal Antibacterial and Antibiotics Country-level Value Analysis
  1. 7.1 Global Animal Antibacterial and Antibiotics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal Antibacterial and Antibiotics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Animal Antibacterial and Antibiotics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Animal Antibacterial and Antibiotics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Animal Antibacterial and Antibiotics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Animal Antibacterial and Antibiotics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Animal Antibacterial and Antibiotics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogénesis Bagó
  2. 8.1.1 Biogénesis Bagó Company Information
  3. 8.1.2 Biogénesis Bagó Business Overview
  4. 8.1.3 Biogénesis Bagó Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biogénesis Bagó Animal Antibacterial and Antibiotics Product Portfolio
  6. 8.1.5 Biogénesis Bagó Recent Developments
  7. 8.2 Boehringer Ingelheim Vetmedica
  8. 8.2.1 Boehringer Ingelheim Vetmedica Company Information
  9. 8.2.2 Boehringer Ingelheim Vetmedica Business Overview
  10. 8.2.3 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Vetmedica Animal Antibacterial and Antibiotics Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Vetmedica Recent Developments
  13. 8.3 Ceva Santé Animale
  14. 8.3.1 Ceva Santé Animale Company Information
  15. 8.3.2 Ceva Santé Animale Business Overview
  16. 8.3.3 Ceva Santé Animale Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Santé Animale Animal Antibacterial and Antibiotics Product Portfolio
  18. 8.3.5 Ceva Santé Animale Recent Developments
  19. 8.4 Dechra Pharmaceuticals
  20. 8.4.1 Dechra Pharmaceuticals Company Information
  21. 8.4.2 Dechra Pharmaceuticals Business Overview
  22. 8.4.3 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dechra Pharmaceuticals Animal Antibacterial and Antibiotics Product Portfolio
  24. 8.4.5 Dechra Pharmaceuticals Recent Developments
  25. 8.5 ECO Animal Health
  26. 8.5.1 ECO Animal Health Company Information
  27. 8.5.2 ECO Animal Health Business Overview
  28. 8.5.3 ECO Animal Health Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ECO Animal Health Animal Antibacterial and Antibiotics Product Portfolio
  30. 8.5.5 ECO Animal Health Recent Developments
  31. 8.6 Elanco
  32. 8.6.1 Elanco Company Information
  33. 8.6.2 Elanco Business Overview
  34. 8.6.3 Elanco Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Animal Antibacterial and Antibiotics Product Portfolio
  36. 8.6.5 Elanco Recent Developments
  37. 8.7 Huvepharma
  38. 8.7.1 Huvepharma Company Information
  39. 8.7.2 Huvepharma Business Overview
  40. 8.7.3 Huvepharma Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huvepharma Animal Antibacterial and Antibiotics Product Portfolio
  42. 8.7.5 Huvepharma Recent Developments
  43. 8.8 Merial
  44. 8.8.1 Merial Company Information
  45. 8.8.2 Merial Business Overview
  46. 8.8.3 Merial Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merial Animal Antibacterial and Antibiotics Product Portfolio
  48. 8.8.5 Merial Recent Developments
  49. 8.9 Neogen
  50. 8.9.1 Neogen Company Information
  51. 8.9.2 Neogen Business Overview
  52. 8.9.3 Neogen Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Neogen Animal Antibacterial and Antibiotics Product Portfolio
  54. 8.9.5 Neogen Recent Developments
  55. 8.10 Norbrook
  56. 8.10.1 Norbrook Company Information
  57. 8.10.2 Norbrook Business Overview
  58. 8.10.3 Norbrook Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Norbrook Animal Antibacterial and Antibiotics Product Portfolio
  60. 8.10.5 Norbrook Recent Developments
  61. 8.11 Orion
  62. 8.11.1 Orion Company Information
  63. 8.11.2 Orion Business Overview
  64. 8.11.3 Orion Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Orion Animal Antibacterial and Antibiotics Product Portfolio
  66. 8.11.5 Orion Recent Developments
  67. 8.12 Phibro Animal Health
  68. 8.12.1 Phibro Animal Health Company Information
  69. 8.12.2 Phibro Animal Health Business Overview
  70. 8.12.3 Phibro Animal Health Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Phibro Animal Health Animal Antibacterial and Antibiotics Product Portfolio
  72. 8.12.5 Phibro Animal Health Recent Developments
  73. 8.13 Vétoquinol
  74. 8.13.1 Vétoquinol Company Information
  75. 8.13.2 Vétoquinol Business Overview
  76. 8.13.3 Vétoquinol Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vétoquinol Animal Antibacterial and Antibiotics Product Portfolio
  78. 8.13.5 Vétoquinol Recent Developments
  79. 8.14 Virbac
  80. 8.14.1 Virbac Company Information
  81. 8.14.2 Virbac Business Overview
  82. 8.14.3 Virbac Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Virbac Animal Antibacterial and Antibiotics Product Portfolio
  84. 8.14.5 Virbac Recent Developments
  85. 8.15 Vitafor
  86. 8.15.1 Vitafor Company Information
  87. 8.15.2 Vitafor Business Overview
  88. 8.15.3 Vitafor Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Vitafor Animal Antibacterial and Antibiotics Product Portfolio
  90. 8.15.5 Vitafor Recent Developments
  91. 8.16 Bayer HealthCare
  92. 8.16.1 Bayer HealthCare Company Information
  93. 8.16.2 Bayer HealthCare Business Overview
  94. 8.16.3 Bayer HealthCare Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bayer HealthCare Animal Antibacterial and Antibiotics Product Portfolio
  96. 8.16.5 Bayer HealthCare Recent Developments
  97. 8.17 Merck Animal Health
  98. 8.17.1 Merck Animal Health Company Information
  99. 8.17.2 Merck Animal Health Business Overview
  100. 8.17.3 Merck Animal Health Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Merck Animal Health Animal Antibacterial and Antibiotics Product Portfolio
  102. 8.17.5 Merck Animal Health Recent Developments
  103. 8.18 Zoetis
  104. 8.18.1 Zoetis Company Information
  105. 8.18.2 Zoetis Business Overview
  106. 8.18.3 Zoetis Animal Antibacterial and Antibiotics Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Zoetis Animal Antibacterial and Antibiotics Product Portfolio
  108. 8.18.5 Zoetis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst